Abstract:Abstract Teledermatology has been shown to be accurate in the diagnosis of skin cancer. The number of skin cancer referrals to secondary care has surged and dermatology departments are under increasing pressure to meet cancer pathway targets. The aim of this study was to compare service outcomes for teledermatology vs. conventional face-to-face review. We performed a retrospective review of adult patients referred by general practitioners for suspected skin cancer via the 2-week-wait pathway from August 2022 to February 2023. Patients were assessed either by conventional face-to-face appointment or via teledermatology. Teledermatology patients completed a questionnaire and were seen by a photographer in the community who took regional, macroscopic and dermoscopic images. The primary outcomes were times from referral to first clinical appointment and to surgery (if applicable), surgical intervention rate, and histological diagnoses (if applicable). Statistical analysis was performed using Prism software (GraphPad Software, La Jolla, CA, USA). Comparisons between groups were performed with the Mann–Whitney U-test and Fisher exact, as appropriate. P-values < 0.05 were considered statistically significant. In total, 50 consecutive patients assessed by a single clinician via teledermatology were compared with 100 randomly selected patients assessed by the same clinician via face-to-face review. More than half of patients were female in both groups (52% teledermatology vs. 58% face-to-face). The teledermatology group was older ,with a mean age of 56.7 years (SD 18.5) vs. 40 years (SD 20.5), P < 0.001. The median waiting time for a clinical appointment was slightly longer in the teledermatology group [16.5 days (SD 8.5) vs. 14 days (SD 5.4) for face to face (P < 0.001)]. The median waiting time from receipt of referral to surgery was similar in both groups [38 days (SD 17.3) for teledermatology vs. 32 days (SD 12.5) for face to face (P = 0.4)]. The median waiting time from decision to treat to surgery was similar in both groups [21 days (SD 17.3) for teledermatology vs. 20 days (SD 11.7) for face to face (P = 0.9)]. There was no significant difference in the diagnostic biopsy/therapeutic excision rate (34% for teledermatology vs. 27% for face to face, P = 0.37), or in the proportion of benign, dysplastic and malignant lesions biopsied or excised (P = 0.75). Over one-third of patients reviewed by teledermatology were discharged without the need to attend hospital. In conclusion, this model of teledermatology offers a robust way to assess suspected cancer, with biopsy rates and eventual diagnoses comparable with conventional models. The use of professional medical photography may delay initial review, but higher-quality images are associated with improved diagnostic accuracy.

The NHS two week wait skin cancer referral pathway: analysis and recommendations for process improvement

P033 Do suspected cancer pathway referrals to dermatology meet the NICE criteria for referral?

BT25 Successfully utilizing a novel teledermatology pathway in a suspected skin cancer clinic: improving patient experience and reducing time from referral to assessment

A retrospective audit of the triage process introduced for breast referrals received during the Covid-19 pandemic.

The two-week rule colorectal cancer pathway: an update on recent practice, the unsustainable burden on diagnostics and the role of faecal immunochemical testing

P029 Targeted skin examinations: a reasonable compromise?

BT03 A picture paints a thousand words: simple solutions for optimizing the flow of urgent skin cancer referrals

A novel remote assessment pathway to streamline the management of two-week-wait suspected head and neck cancer referrals: a prospective analysis of 660 patients

BT21 Teledermatology pathway performance for detection of all skin cancer categories

The Use of Teledermatology for Skin Cancer Referrals: A Retrospective Study in a Single Tertiary Centre

BT12 Great expectations: implementing artificial intelligence software into a regional skin cancer teledermatology service

A Superclinic model for tackling skin cancer referrals

BT06 Using artificial intelligence to triage skin cancer referrals: outcomes from a pilot study

Evaluation of a pilot of a community virtual triage for breast symptoms outside of usual primary or secondary care pathways

Clinical and non-clinical team collaboration to develop breast referral triage to improve service delivery in secondary care

BT32 Teledermatology service evaluation compared with standard face-to-face review for 2-week-wait skin cancer referrals

P024 Skin cancer referrals by nonmedical practitioners: a prospective observational study

Adapting the investigation of patients on urgent suspected cancer pathway with lower gastrointestinal symptoms across Wales during COVID-19

BT09 Multicentre prospective clinical performance analysis of an artificial intelligence as a medical device deployed within urgent suspected skin cancer pathways

Socioeconomic Inequality in the Head and Neck Cancer Referral System: Redressing the Balance

O13 42 590 fewer skin tumours diagnosed in England during the 2020 COVID pandemic: greatest reductions in melanoma in situ , stage I melanomas and basal cell carcinomas